Streetbeat News

Partnerships

AMKR

ARM

CMC

EQIX

INFY

SIG

Jim Cramer discussed various companies on CNBC's 'Mad Money Lightning Round,' praising Equinix, Signet Jewelers, Infosys, and Commercial Metals Company, while noting a lock-up expiration for Arm Holdings. Equinix reported strong Q4 sales and a dividend, Signet Jewelers appointed a new board member, Infosys launched its Responsible AI Suite, and Commercial Metals is expected to report earnings soon. Amkor received a neutral rating from Goldman Sachs.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 2:29 pm

DSX

Diana Shipping Inc. (DSX) has entered into a time charter contract with Louis Dreyfus Company for the m/v Crystalia, an Ice Class Panamax dry bulk vessel. The contract, starting in Q2 2024, has a gross charter rate of $13,900 minus a 5% commission, for 21 to 25 months, expected to generate $8.76 million in gross revenue. Following the sale of m/v Houston and m/v Artemis, DSX's fleet will include 38 vessels, with plans to add two methanol dual fuel Kamsarmax vessels by 2028. The current fleet's capacity is about 4.5 million dwt.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 2:19 pm

GPS

Gap Inc's Athleta brand has announced a five-year partnership with Olympic swimmer Katie Ledecky, aiming to empower women and girls through the Power of She Collective. Ledecky will advise on Athleta's impact platform and participate in product testing. Gap shares rose 0.32% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 01, 2024 | 2:07 pm

NVDA

Nvidia's stock has soared over $800, marking a significant milestone as the company transitions from PC gaming to a leader in AI technology. Despite concerns of overvaluation and potential short-term market corrections, Nvidia's impressive 56% increase in stock value early in the year, followed by a 16% rise post-Q4 earnings, showcases strong performance and investor confidence. Technical analysis suggests a support zone around $716, with future resistance anticipated at the $1000 mark. Nvidia's collaboration with Meta to build the world's fastest AI supercomputer further cements its position in the AI space.

Portfolio Pulse from Zaheer Anwari

March 01, 2024 | 1:52 pm

NSC

Ancora Holdings Group, LLC and its affiliates (the Investor Group), holding a significant stake in Norfolk Southern Corporation (NYSE:NSC), issued an open letter criticizing the company's leadership and proposing changes. They highlighted CEO Alan Shaw's 37% pay raise despite poor performance, including the East Palestine derailment. The Investor Group nominated eight candidates for the board and proposed a new management team, urging a focus on safety, growth, and value creation. They criticized the current board's actions as serving CEO interests over shareholders and called for a fact-based election contest.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:37 pm

SCOR

TGNA

Comscore, Inc. (NASDAQ:SCOR) and TEGNA Inc. (NYSE:TGNA) have entered into a multi-year agreement for local linear and cross-platform audience measurement. Comscore will continue as a key measurement partner across all TEGNA markets, providing metrics for local TV, major affiliate, and digital businesses. This partnership aims to deliver value for TEGNA's advertisers across linear and digital platforms by leveraging Comscore's local market data and cross-platform capabilities. Financial details of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:35 pm

KNTE

Kinnate Biopharma Inc. has sold its investigational pan-RAF inhibitor, exarafenib, and other assets to Pierre Fabre Laboratories for up to $31M. This sale is part of Kinnate's strategic alternatives exploration. Pierre Fabre will assume all ongoing program costs, with Kinnate receiving $500,000 at closing and up to $30.5M contingent on future milestones. The deal aims to expand the global reach of targeted therapies for solid tumors.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:34 pm

TGT

Target Corporation (NYSE:TGT) offers a 2.88% annual dividend yield, equating to $1.10 per share quarterly or $4.40 annually. To earn $500 monthly from dividends, an investment of approximately $208,583 or 1,364 shares is needed. The article also highlights Target's upcoming Q4 earnings release on March 5, 2024, with expected earnings of $2.41 per share and revenue of $31.83 billion. Additionally, Target announced a collaboration with Diane von Furstenberg for a spring collection.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:33 pm

EOLS

Evolus, Inc. (NASDAQ:EOLS) announced its dermal filler product (Evolysse™/Estyme® Lift) showed statistical superiority over Restylane-L in a European study, meeting its primary endpoint of non-inferiority at 3 and 6 months. The company plans to launch the first-generation Cold HA Technology globally in 2025, with FDA filing expected in summer 2024. The study, which enrolled 45 patients, demonstrated the safety and effectiveness of the Evolysse™/Estyme® Lift filler. Additionally, Evolus has entered into exclusive distribution agreements with Symatese for the US and Europe, expanding its market by 78% to approximately $6 billion.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:32 pm

ABBV

AMGN

MDT

Wall Street's most accurate analysts have provided updates on three high-dividend yielding health care stocks: Amgen Inc. (AMGN), Medtronic plc (MDT), and AbbVie Inc. (ABBV). These updates include changes in price targets and ratings, reflecting the analysts' views on the stocks' future performance. Additionally, recent news for each company includes Amgen's new manufacturing site, Medtronic's ITC action against Axonics, and AbbVie's partnership with OSE Immunotherapeutics.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 12:52 pm